Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Ash
Ash received his MA in Economics from Columbia University. He graduated with a degree in Electrical Engineering and Econometrics from the University of Alabama at Birmingham (summa cum laude, Tau Beta Pi).
Ameen
Ameen is an MD candidate at Harvard. A Rhodes Scholar and Goldwater Scholarship recipient, he holds a Master's in Public Policy (Oxford) and a Bachelor's in Neuroscience and Translational Research (University of Alabama).